Navigating the selection of a qualified laboratory supplier for bioregulatory compounds requires strict attention to analytical verification and chemical integrity. Vilon (Lysyl-glutamic acid) is an investigated short dipeptide evaluated in preclinical models for its potential influence on gene expression and mucosal tissue architecture. PX1 Research delivers USA-manufactured, research-grade Vilon accompanied by lot-specific documentation to support rigorous in vitro and animal research protocols.
Navigating the selection of a qualified laboratory supplier for bioregulatory compounds requires strict attention to analytical verification and chemical integrity. Vilon (Lysyl-glutamic acid) is an investigated short dipeptide evaluated in preclinical models for its potential influence on gene expression and mucosal tissue architecture. PX1 Research delivers USA-manufactured, research-grade Vilon accompanied by lot-specific documentation to support rigorous in vitro and animal research protocols.
Qualified institutional investigators seeking to buy Vilon from a reliable intestinal support supplier must prioritize verified chemical identity, high purity, and transparent lot testing. PX1 Research supplies synthetic Vilon peptide manufactured under stringent laboratory standards, backed by third-party High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) documentation. Every batch undergoes rigorous endotoxin assays to ensure reproducible results across cellular and animal model systems.
Vilon is supplied strictly as a lyophilized research chemical for laboratory research use only. It is not intended for human consumption, clinical diagnostic procedures, or therapeutic administration.
Vilon is a synthetic ultra-short peptide composed of two amino acids: L-lysine and L-glutamic acid (Lys-Glu). Originating from broader investigations into thymic and bioregulatory peptide fractions, this simple dipeptide structure exhibits notable biological stability and high cellular permeability in laboratory assays.
Researchers studying structural chemistry focus on Vilon due to its ability to interact directly with nuclear chromatin. In vitro assays demonstrate that short peptide sequences like Lys-Glu can translocate across cellular membranes without requiring specialized transporter complexes, allowing direct interaction with specific histone tails and DNA sequence regions. Investigators exploring broader bioregulatory pathways can examine additional low-molecular-weight compounds within our research library hub.
In preclinical gastrointestinal models, researchers have investigated Vilon for its role in maintaining epithelial barrier integrity and supporting tissue regeneration. Rodent models of mucosal injury suggest that Lys-Glu administration correlates with optimized tight junction protein expression and reduced localized inflammatory markers.
In vitro studies using intestinal epithelial cell cultures indicate that Vilon exposure may stimulate cellular proliferation and migration following mechanical disruption. Researchers measuring brush-border enzyme activity observed that dipeptide exposure helped preserve mucosal enzymatic function under oxidative stress conditions. These findings position Vilon as a key target for investigating barrier function mechanisms, alongside complementary tools available in our all peptides directory.
A primary focus of contemporary research into Vilon involves its epigenetic mechanisms of action. Epigenetic studies demonstrate that Lys-Glu can induce decondensation of heterochromatin in cultured cells, promoting the accessibility of specific promoter regions responsible for tissue repair and protein synthesis.
Preclinical data indicate that Vilon modulates expression profiles for cytokines, heat shock proteins, and anti-oxidative enzymes. By altering gene transcription without mutating underlying DNA sequences, Vilon provides a focused model for studying how short amino acid sequences regulate homeostatic responses in damaged or aging epithelial tissues. For deeper theoretical context, review our analysis on Vilon epigenetic mechanisms.
When designing gastrointestinal or mucosal integrity studies, investigators frequently compare Vilon against other established research peptides targeting epithelial repair and cellular protection. While Vilon operates primarily through chromatin uncoiling and direct transcriptional regulation, compounds like BPC-157 work largely through angiogenic signaling pathways and focal adhesion kinase activation.
Similarly, researchers studying inflammatory modulation often evaluate the tripeptide KPV, which targets NF-kB signaling pathways to suppress pro-inflammatory cascade activity. For tight junction permeability assays, Larazotide is frequently utilized as a direct antagonist of zonulin-mediated pathway disruption. Comparing these distinct mechanisms allows laboratory teams to construct multi-target protocols for studying complex intestinal pathologies in vitro.
Selecting a supplier for specialized research compounds requires assessing their analytical capabilities and quality assurance protocols. Because small impurities or residual organic solvents can alter cellular assays and distort experimental outcomes, research teams must demand complete transparency.
A dependable supplier must provide batch-specific documentation verified by independent testing laboratories. Institutional buyers should ensure their supplier utilizes ISO 17025 accredited testing facilities, maintains domestic US manufacturing controls, and provides transparent lot tracking from synthesis through final packaging.
PX1 Research enforces a multi-step analytical protocol for every lot of Vilon produced. Chemical identity and quantitative purity are confirmed using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring a purity threshold of 98% or higher. Mass Spectrometry (MS) is conducted concurrently to verify exact molecular mass and confirm the absence of truncated peptide fragments.
Because intestinal epithelial models and cell culture lines are highly sensitive to bacterial contaminants, PX1 Research subjects all peptide lots to Chromogenic Reagent Endotoxin Testing (LAL assay). Guaranteeing low endotoxin levels prevents non-specific inflammatory activation in culture, protecting the validity of your experimental data. Qualified institutional researchers can apply for streamlined procurement via our wholesale lab account portal.
Vilon is supplied as a sterile, lyophilized white powder to maximize chemical stability during storage and transit. For laboratory preparation, the compound should be reconstituted using sterile, bacteriostatic water or laboratory-grade phosphate-buffered saline (PBS, pH 7.4) depending on the requirements of your specific assay.
To reconstitute, allow the vial to reach room temperature before introducing the solvent along the inner glass wall of the vial. Gently swirl the container until fully dissolved; avoid vigorous vortexing, which can introduce shear stress and disrupt molecular structure. Reconstituted stock solutions intended for cell culture applications should be handled under a laminar flow hood to maintain sterility.
Lyophilized Vilon should be stored in a commercial freezer at -20°C for long-term preservation, protected from light and moisture. Under these conditions, the peptide remains stable for extended periods without measurable degradation.
Once reconstituted into solution, stock aliquots should be divided into single-use working volumes to minimize freeze-thaw cycles. Reconstituted solutions stored at 2°C to 8°C should be used within short experimental windows, while frozen aliquots stored at -20°C or -80°C maintain analytical stability for prolonged testing schedules.
What is the primary scientific focus when researching Vilon?
Preclinical research focuses on Vilon's role as a chromatin-modulating dipeptide (Lys-Glu). Studies investigate its interaction with nuclear structures, its influence on gene expression for epithelial repair proteins, and its potential to preserve mucosal barrier integrity in cell culture and animal models.
How does PX1 Research verify the purity of Vilon?
PX1 Research subjects every lot of Vilon to independent third-party laboratory analysis using RP-HPLC to confirm purity levels ≥98% and Mass Spectrometry to verify precise molecular identity. Certificates of Analysis (COAs) are provided for full transparency.
Are endotoxin levels tested on Vilon batches?
Yes. Every batch of Vilon undergoes LAL chromogenic endotoxin testing to ensure low endotoxin limits, preventing artifactual inflammatory responses in sensitive in vitro and animal models.
Is Vilon suitable for human administration or clinical use?
No. Vilon supplied by PX1 Research is strictly designated for laboratory research use only. It is not approved for human consumption, clinical trials, or therapeutic use.
What diluent should be used to reconstitute Vilon for lab assays?
Vilon is typically reconstituted using sterile laboratory-grade Bacteriostatic Water or Phosphate-Buffered Saline (PBS, pH 7.4), depending on the requirements of the downstream cellular or enzymatic protocol.
Where is PX1 Research Vilon manufactured and shipped from?
All PX1 Research compounds are manufactured in domestic US facilities operating under strict quality controls and shipped directly from distribution hubs located in California and Arizona.
How does Vilon compare structurally to BPC-157?
Vilon is an ultra-short dipeptide (Lys-Glu) focused on epigenetic regulation and chromatin interaction, whereas BPC-157 is a 15-amino-acid pentadecapeptide primarily investigated for angiogenic signaling and focal adhesion pathways in tissue repair models.
What are the recommended storage conditions for lyophilized Vilon?
Lyophilized Vilon should be stored at -20°C in a dry, dark environment. Once reconstituted, solutions should be aliquoted and kept at -20°C or -80°C to avoid repeated freeze-thaw cycles.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.